LINC02035: A Drug Target / Disease Biomarker (G100129550)

Target Name: LINC02035

NCBI ID: G100129550

LINC02035

Other Name(s): long intergenic non-protein coding RNA 2035 | Long intergenic non-protein coding RNA 2035

LINC02035: A Drug Target / Disease Biomarker

LINC02035 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of the cell cycle, which is the process by which cells grow, divide, and replicate their genetic material. LINC02035 is also involved in the regulation of cell survival and in the development of various diseases, including cancer.

Recent studies have identified LINC02035 as a potential drug target for a variety of diseases, including cancer. LINC02035 has been shown to be highly expressed in many types of cancer, including breast, ovarian, and prostate cancer. It has also been shown to play a role in the regulation of cell cycle progression and the development of cancer stem cells.

One of the key advantages of LINC02035 as a drug target is its widespread expression in various tissues of the body. This makes it less likely that any drug that targets LINC02035 will have a significant impact on all cells in the body, which could reduce the risk of side effects. Additionally, LINC02035 is well-validated as a potential drug target, which means that it has been shown to be involved in a wide range of cellular processes that are important for the development and progression of cancer.

Another potential advantage of LINC02035 as a drug target is its involvement in the regulation of cell survival. LINC02035 has been shown to play a role in the regulation of cell cycle progression and the determination of cell survival. It has been shown to interact with a variety of proteins that are involved in the regulation of cell survival, including the protein p53. p53 is a well-known protein that is involved in the regulation of cell cycle growth and the prevention of cancer. By interacting with p53, LINC02035 may be able to influence the activity of p53 and contribute to the regulation of cell survival.

In addition to its involvement in cell survival, LINC02035 has also been shown to play a role in the development of cancer stem cells. Cancer stem cells are a type of cell that have the ability to divide and proliferate in an uncontrolled manner, which allows them to contribute to the development and progression of cancer. LINC02035 has been shown to play a role in the regulation of stem cell proliferation and the development of cancer stem cells.

Overall, LINC02035 is a protein that has been shown to be involved in a wide range of cellular processes that are important for the development and progression of cancer. As a potential drug target, LINC02035 has the potential to be an effective treatment for a variety of diseases, including cancer. Further research is needed to fully understand the role of LINC02035 as a drug target and to develop safe and effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 2035

The "LINC02035 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02035 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets